Welcome to the Community Star Consultant Conference! Hosted in Hangzhou, China in November 2017, this conference aims to delve into the comprehensive management of Type 2 Diabetes Mellitus (T2DM) and the clinical experiences with repaglinide and detemir insulin. It invites professionals to participate and share the latest research advancements, hoping to enhance clinical practice and patient management. The agenda includes a series of discussions and presentations on topics such as suitable patients for repaglinide (NovoLog) and detemir insulin (NovoPen), market strategies for NovoLog, and new data on the epidemiology of diabetes in China. The event is designed and produced by Eqxiu.com, offering users the convenience of online design with a rich variety of templates to quickly create such H5 presentations.